Structural basis for bifunctional peptide recognition at human δ-opioid receptor
Serial femtosecond crystallography of the human δ-opioid receptor in complex with an endomorphin-derived peptide reveals interactions that are important for understanding the pharmacology of opioid peptides and developing analgesics with reduced side effects. Bifunctional μ- and δ-opioid receptor (O...
Saved in:
Published in | Nature structural & molecular biology Vol. 22; no. 3; pp. 265 - 268 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.03.2015
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Serial femtosecond crystallography of the human δ-opioid receptor in complex with an endomorphin-derived peptide reveals interactions that are important for understanding the pharmacology of opioid peptides and developing analgesics with reduced side effects.
Bifunctional μ- and δ-opioid receptor (OR) ligands are potential therapeutic alternatives, with diminished side effects, to alkaloid opiate analgesics. We solved the structure of human δ-OR bound to the bifunctional δ-OR antagonist and μ-OR agonist tetrapeptide H-Dmt-Tic-Phe-Phe-NH
2
(DIPP-NH
2
) by serial femtosecond crystallography, revealing a
cis
-peptide bond between H-Dmt and Tic. The observed receptor-peptide interactions are critical for understanding of the pharmacological profiles of opioid peptides and for development of improved analgesics. |
---|---|
Bibliography: | U54 GM094618; R01 GM108635; R01 GM095583; DA-004443; Y1-CO-1020 USDOE Office of Science (SC), Basic Energy Sciences (BES) National Institutes of Health (NIH) Present address: Center for Applied Structural Discovery at the Biodesign Institute, Arizona State University, Tempe, Arizona, USA Present address: National Science Foundation BioXFEL Science and Technology Center, Buffalo, New York, USA Present address: The Bridge@USC, University of Southern California, Los Angeles, California, USA Present address: Celgene Corporation, San Diego, California, USA |
ISSN: | 1545-9993 1545-9985 |
DOI: | 10.1038/nsmb.2965 |